Esperion Theraptc (ESPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -97,165 | -201,810 | -166,988 | -74,978 | -49,784 |
| Depreciation Amortization | 119 | 48 | 592 | 1,266 | 944 |
| Accounts payable and accrued liabilities | -16,055 | 24,446 | 15,758 | 3,888 | -1,333 |
| Other Working Capital | -7,299 | 29,156 | 16,489 | 10,025 | -2,089 |
| Other Operating Activity | 50,059 | -478 | 2,847 | 12,069 | 14,106 |
| Operating Cash Flow | $-70,341 | $-148,638 | $-131,302 | $-47,730 | $-38,156 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -953 | -151 | -19 | -94 | -301 |
| Purchase Of Investment | -34,326 | -25,481 | -219,577 | -197,230 | -280,559 |
| Sale Of Investment | 99,510 | 166,081 | 183,743 | 207,442 | 120,792 |
| Investing Cash Flow | $64,231 | $140,449 | $-35,853 | $10,118 | $-160,068 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -1,049 | -1,709 | -1,604 | -638 |
| Common Stock Issued | 11,771 | 11,743 | 165,167 | 45 | 191,160 |
| Other Financing Activity | 124,424 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $136,195 | $10,694 | $163,458 | $-1,559 | $190,522 |
| Beginning Cash Position | 36,973 | 34,468 | 38,165 | 77,336 | 85,038 |
| End Cash Position | 167,058 | 36,973 | 34,468 | 38,165 | 77,336 |
| Net Cash Flow | $130,085 | $2,505 | $-3,697 | $-39,171 | $-7,702 |
| Free Cash Flow | |||||
| Operating Cash Flow | -70,341 | -148,638 | -131,302 | -47,730 | -38,156 |
| Capital Expenditure | -953 | -151 | -19 | -94 | -325 |
| Free Cash Flow | -71,294 | -148,789 | -131,321 | -47,824 | -38,481 |